Skip to content

Amandeep Singh, DO

NPI 1245726074ActiveIndividual· Internal Medicine, Pulmonary Disease· Galveston, TX

Internal Medicine, Pulmonary Disease (DO) in Galveston, Texas, licensed in TX, with an NPI issued in July 2018. Part D covered 57 prescriptions written in 2024, 86% of them generic. Genzyme Corporation was the largest of 3 companies reporting payments in 2025, $618.66 in all, mostly food and beverage.

Overview

NPI1245726074
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedJul 5, 2018
Last updated in NPPESAug 4, 2024
Certified by providerJun 21, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (NY)

Part D prescriptions in 2024

Prescriptions (claims)57 · 93 30-day fills
Patients20
Total drug cost$5,614
Generic share86% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$618.66 · 6 payments from 3 companies
  • 2024$248.72 · 3 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Genzyme Corporation$465.484
Inspire Medical Systems, Inc.$120.611
Insmed, Inc.$32.571

What the 2025 payments were for

  • Food and Beverage$618.66 · 6 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other pulmonologists in Galveston

All 18 pulmonologists in Galveston · All pulmonologists in Texas